SLC6A3 coding variant Ala559Val found in two autism probands alters dopamine transporter function and trafficking
暂无分享,去创建一个
J. Sutcliffe | H. Coon | R. Blakely | J. Veenstra-VanderWeele | E. Bowton | A. Galli | P. Hamilton | C. Saunders | K. Erreger | D. Sakrikar | L. Henry | Heinrich J. G. Matthies | I. Reddy | N. Campbell | D. Sakrikar
[1] J. Matson,et al. Autism severity as a predictor of inattention and impulsivity in toddlers , 2015, Developmental Neurorehabilitation.
[2] R. Landa,et al. Association between severity of behavioral phenotype and comorbid attention deficit hyperactivity disorder symptoms in children with autism spectrum disorders , 2014, Autism : the international journal of research and practice.
[3] Evan J. Kyzar,et al. Decoding the contribution of dopaminergic genes and pathways to autism spectrum disorder (ASD) , 2014, Neurochemistry International.
[4] Eric Gouaux,et al. X-ray structure of dopamine transporter elucidates antidepressant mechanism , 2013, Nature.
[5] J. Matson,et al. The relationship between autism spectrum disorders and attention-deficit/hyperactivity disorder: an overview. , 2013, Research in developmental disabilities.
[6] J. Sutcliffe,et al. De novo mutation in the dopamine transporter gene associates dopamine dysfunction with autism spectrum disorder , 2013, Molecular Psychiatry.
[7] Charles J. Lynch,et al. Underconnectivity between voice-selective cortex and reward circuitry in children with autism , 2013, Proceedings of the National Academy of Sciences.
[8] M. Leitges,et al. Protein kinase Cβ is a modulator of the dopamine D2 autoreceptor‐activated trafficking of the dopamine transporter , 2013, Journal of neurochemistry.
[9] B. Franke,et al. The dopamine transporter haplotype and reward-related striatal responses in adult ADHD , 2013, European Neuropsychopharmacology.
[10] D. Murphy,et al. Pharmacological treatments prescribed to people with autism spectrum disorder (ASD) in primary health care , 2013, Psychopharmacology.
[11] Kathryn Roeder,et al. Analysis of Rare, Exonic Variation amongst Subjects with Autism Spectrum Disorders and Population Controls , 2013, PLoS genetics.
[12] Kathryn Roeder,et al. Rare Complete Knockouts in Humans: Population Distribution and Significant Role in Autism Spectrum Disorders , 2013, Neuron.
[13] W. Roberts,et al. Clinical Practice Pathways for Evaluation and Medication Choice for Attention-Deficit/Hyperactivity Disorder Symptoms in Autism Spectrum Disorders , 2012, Pediatrics.
[14] Evan M Gordon,et al. Effect of dopamine transporter genotype on intrinsic functional connectivity depends on cognitive state. , 2012, Cerebral cortex.
[15] T. Takumi,et al. Altered Serotonin, Dopamine and Norepinepherine Levels in 15q Duplication and Angelman Syndrome Mouse Models , 2012, PloS one.
[16] K. Roelofs,et al. Dopamine transporter polymorphisms affect social approach–avoidance tendencies , 2012, Genes, brain, and behavior.
[17] Bernie Devlin,et al. Genetic architecture in autism spectrum disorder. , 2012, Current opinion in genetics & development.
[18] Kenny Q. Ye,et al. De Novo Gene Disruptions in Children on the Autistic Spectrum , 2012, Neuron.
[19] Michael Gill,et al. Attention Deficit/Hyperactivity Disorder-Derived Coding Variation in the Dopamine Transporter Disrupts Microdomain Targeting and Trafficking Regulation , 2012, The Journal of Neuroscience.
[20] Michael F. Walker,et al. De novo mutations revealed by whole-exome sequencing are strongly associated with autism , 2012, Nature.
[21] Evan T. Geller,et al. Patterns and rates of exonic de novo mutations in autism spectrum disorders , 2012, Nature.
[22] S. Roux,et al. Psychostimulants for ADHD-like symptoms in individuals with autism spectrum disorders , 2012, Expert review of neurotherapeutics.
[23] Bradley P. Coe,et al. Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations , 2012, Nature.
[24] W. A. Owens,et al. Rescue of Dopamine Transporter Function in Hypoinsulinemic Rats by a D2 Receptor–ERK-Dependent Mechanism , 2012, The Journal of Neuroscience.
[25] G. Dichter,et al. Reward Circuitry Function in Autism During Face Anticipation and Outcomes , 2011, Journal of Autism and Developmental Disorders.
[26] Scott J. Russo,et al. Impaired Striatal Akt Signaling Disrupts Dopamine Homeostasis and Increases Feeding , 2011, PloS one.
[27] U. Gether,et al. SLC6 Neurotransmitter Transporters: Structure, Function, and Regulation , 2011, Pharmacological Reviews.
[28] W. Staal,et al. Brief Report: The Dopamine-3-Receptor Gene (DRD3) is Associated with Specific Repetitive Behavior in Autism Spectrum Disorder (ASD) , 2011, Journal of Autism and Developmental Disorders.
[29] Boris Yamrom,et al. Rare De Novo and Transmitted Copy-Number Variation in Autistic Spectrum Disorders , 2011, Neuron.
[30] Kathryn Roeder,et al. Multiple Recurrent De Novo CNVs, Including Duplications of the 7q11.23 Williams Syndrome Region, Are Strongly Associated with Autism , 2011, Neuron.
[31] H. Kokki,et al. Effects of Fluoxetine Treatment on Striatal Dopamine Transporter Binding and Cerebrospinal Fluid Insulin-Like Growth Factor-1 in Children with Autism , 2011, Neuropediatrics.
[32] J. Rothman,et al. Erratum: A lateralized brain network for visuospatial attention , 2011, Nature Neuroscience.
[33] K. Schroder,et al. Macrophage Activation and Differentiation Signals Regulate Schlafen-4 Gene Expression: Evidence for Schlafen-4 as a Modulator of Myelopoiesis , 2011, PloS one.
[34] E. Hatchwell,et al. Association of DRD4 polymorphism with severity of oppositional defiant disorder, separation anxiety disorder and repetitive behaviors in children with autism spectrum disorder , 2010, The European journal of neuroscience.
[35] J. Javitch,et al. Akt-dependent and isoform-specific regulation of dopamine transporter cell surface expression. , 2010, ACS chemical neuroscience.
[36] Gary D Bader,et al. Functional impact of global rare copy number variation in autism spectrum disorders , 2010, Nature.
[37] R. Blakely,et al. Dysregulation of Dopamine Transporters via Dopamine D2 Autoreceptors Triggers Anomalous Dopamine Efflux Associated with Attention-Deficit Hyperactivity Disorder , 2010, The Journal of Neuroscience.
[38] R. Poldrack,et al. Reward processing in autism , 2010, Autism research : official journal of the International Society for Autism Research.
[39] A. Newton,et al. Protein kinase C: poised to signal. , 2010, American journal of physiology. Endocrinology and metabolism.
[40] H. Faras,et al. Autism spectrum disorders , 2010, Annals of Saudi medicine.
[41] Yasuomi Ouchi,et al. Brain serotonin and dopamine transporter bindings in adults with high-functioning autism. , 2010, Archives of general psychiatry.
[42] K. Mirnics,et al. Involvement of the PRKCB1 gene in autistic disorder: significant genetic association and reduced neocortical gene expression , 2009, Molecular Psychiatry.
[43] Sarah Curran,et al. A Common Variant in DRD3 Receptor Is Associated with Autism Spectrum Disorder , 2009, Biological Psychiatry.
[44] K. Gadow,et al. Comparative Study of Children With ADHD Only, Autism Spectrum Disorder + ADHD, and Chronic Multiple Tic Disorder + ADHD , 2009, Journal of attention disorders.
[45] S. Robertson,et al. A Closer Look at Amphetamine-Induced Reverse Transport and Trafficking of the Dopamine and Norepinephrine Transporters , 2009, Molecular Neurobiology.
[46] B. Kolachana,et al. Variation in dopamine genes influences responsivity of the human reward system , 2009, Proceedings of the National Academy of Sciences.
[47] J. Gilbert,et al. Examination of association to autism of common genetic variationin genes related to dopamine , 2008, Autism research : official journal of the International Society for Autism Research.
[48] E. Hatchwell,et al. Association of ADHD, tics, and anxiety with dopamine transporter (DAT1) genotype in autism spectrum disorder. , 2008, Journal of child psychology and psychiatry, and allied disciplines.
[49] Edwin H. Cook,et al. Copy-number variations associated with neuropsychiatric conditions , 2008, Nature.
[50] S. Steinberg. Structural basis of protein kinase C isoform function. , 2008, Physiological reviews.
[51] J. Javitch,et al. PI3K signaling supports amphetamine-induced dopamine efflux. , 2008, Biochemical and biophysical research communications.
[52] R. Blakely,et al. Anomalous Dopamine Release Associated with a Human Dopamine Transporter Coding Variant , 2008, The Journal of Neuroscience.
[53] C. Schwartz,et al. A DRD1 haplotype is associated with risk for autism spectrum disorders in male‐only affected sib‐pair families , 2008, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[54] R. Palmiter. Dopamine Signaling in the Dorsal Striatum Is Essential for Motivated Behaviors , 2008, Annals of the New York Academy of Sciences.
[55] Ekaterina Boudanova,et al. Amphetamine-induced decreases in dopamine transporter surface expression are protein kinase C-independent , 2008, Neuropharmacology.
[56] Joshua M. Korn,et al. Association between microdeletion and microduplication at 16p11.2 and autism. , 2008, The New England journal of medicine.
[57] D. Pinto,et al. Structural variation of chromosomes in autism spectrum disorder. , 2008, American journal of human genetics.
[58] J. Javitch,et al. Currents in Response to Rapid Concentration Jumps of Amphetamine Uncover Novel Aspects of Human Dopamine Transporter Function , 2008, The Journal of Neuroscience.
[59] J. Gore,et al. Hypoinsulinemia Regulates Amphetamine-Induced Reverse Transport of Dopamine , 2007, PLoS biology.
[60] A. Björklund,et al. Fifty years of dopamine research , 2007, Trends in Neurosciences.
[61] Kenny Q. Ye,et al. Strong Association of De Novo Copy Number Mutations with Autism , 2007, Science.
[62] J. Javitch,et al. Dopamine Transporter Activity Mediates Amphetamine-Induced Inhibition of Akt through a Ca2+/Calmodulin-Dependent Kinase II-Dependent Mechanism , 2007, Molecular Pharmacology.
[63] J. Javitch,et al. Regulation of Dopamine Transporter Trafficking by Intracellular Amphetamine , 2006, Molecular Pharmacology.
[64] Randy D. Blakely,et al. Sequence variation in the human dopamine transporter gene in children with attention deficit hyperactivity disorder , 2005, Neuropharmacology.
[65] R. Blakely,et al. Expression studies of naturally occurring human dopamine transporter variants identifies a novel state of transporter inactivation associated with Val382Ala , 2005, Neuropharmacology.
[66] B. Guptaroy,et al. Rapid delivery of the dopamine transporter to the plasmalemmal membrane upon amphetamine stimulation , 2005, Neuropharmacology.
[67] A. Philippi,et al. Haplotypes in the gene encoding protein kinase c-beta (PRKCB1) on chromosome 16 are associated with autism , 2005, Molecular Psychiatry.
[68] M. Loder,et al. Nonclassical, distinct endocytic signals dictate constitutive and PKC-regulated neurotransmitter transporter internalization , 2005, Nature Neuroscience.
[69] J. Javitch,et al. Akt Is Essential for Insulin Modulation of Amphetamine-Induced Human Dopamine Transporter Cell-Surface Redistribution , 2005, Molecular Pharmacology.
[70] D. Sulzer,et al. Mechanisms of neurotransmitter release by amphetamines: A review , 2005, Progress in Neurobiology.
[71] B. Guptaroy,et al. Regulation of Amphetamine-stimulated Dopamine Efflux by Protein Kinase C β* , 2005, Journal of Biological Chemistry.
[72] Jonathan A Javitch,et al. Amphetamine induces dopamine efflux through a dopamine transporter channel. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[73] A. Sorkin,et al. Constitutive and Protein Kinase C‐Induced Internalization of the Dopamine Transporter is Mediated by a Clathrin‐Dependent Mechanism , 2005, Traffic.
[74] T. Uchiyama,et al. The clinical necessity for assessing Attention Deficit/Hyperactivity Disorder (AD/HD) symptoms in children with high-functioning Pervasive Developmental Disorder (PDD) , 2004, European Child & Adolescent Psychiatry.
[75] S. Goldstein,et al. The Comorbidity of Pervasive Developmental Disorder and Attention Deficit Hyperactivity Disorder: Results of a Retrospective Chart Review , 2004, Journal of autism and developmental disorders.
[76] T. Autti,et al. Increased presynaptic dopamine function in Asperger syndrome , 2004, Neuroreport.
[77] J. Javitch,et al. Amphetamine Regulation of Dopamine Transport , 2004, Journal of Biological Chemistry.
[78] J. Javitch,et al. N-Terminal Phosphorylation of the Dopamine Transporter Is Required for Amphetamine-Induced Efflux , 2004, PLoS biology.
[79] M. Loder,et al. The Dopamine Transporter Constitutively Internalizes and Recycles in a Protein Kinase C-regulated Manner in Stably Transfected PC12 Cell Lines* , 2003, Journal of Biological Chemistry.
[80] Hideyuki Takahashi,et al. Phenylarsine oxide and H2O2 plus vanadate induce reverse translocation of phorbol-ester-activated PKCbetaII. , 2003, Cell structure and function.
[81] R. Blakely,et al. A Regulated Interaction of Syntaxin 1A with the Antidepressant-Sensitive Norepinephrine Transporter Establishes Catecholamine Clearance Capacity , 2003, The Journal of Neuroscience.
[82] N. Zahniser,et al. Brief, repeated exposure to substrates down‐regulates dopamine transporter function in Xenopus oocytes in vitro and rat dorsal striatum in vivo , 2002, Journal of neurochemistry.
[83] N. Volkow,et al. Loss of Dopamine Transporters in Methamphetamine Abusers Recovers with Protracted Abstinence , 2001, The Journal of Neuroscience.
[84] D. Geschwind,et al. A genomewide screen for autism susceptibility loci. , 2001, American journal of human genetics.
[85] B. Leventhal,et al. The Autism Diagnostic Observation Schedule—Generic: A Standard Measure of Social and Communication Deficits Associated with the Spectrum of Autism , 2000, Journal of autism and developmental disorders.
[86] J. Javitch,et al. Amphetamine-induced loss of human dopamine transporter activity: an internalization-dependent and cocaine-sensitive mechanism. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[87] S. Cichon,et al. Systematic screening for DNA sequence variation in the coding region of the human dopamine transporter gene (DAT1) , 2000, Molecular Psychiatry.
[88] Wolfgang Ziegler,et al. Multiple pathways control protein kinase C phosphorylation , 2000, The EMBO journal.
[89] M. Kavanaugh,et al. Activation of protein kinase C inhibits uptake, currents and binding associated with the human dopamine transporter expressed in Xenopus oocytes. , 1997, The Journal of pharmacology and experimental therapeutics.
[90] S. J. Gatley,et al. Relationship between subjective effects of cocaine and dopamine transporter occupancy , 1997, Nature.
[91] R. Mark Wightman,et al. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter , 1996, Nature.
[92] D. Mochly‐Rosen,et al. C2 Region-derived Peptides Inhibit Translocation and Function of β Protein Kinase C in Vivo(*) , 1995, The Journal of Biological Chemistry.
[93] A. Couteur,et al. Autism Diagnostic Interview-Revised: A revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders , 1994, Journal of autism and developmental disorders.
[94] H. Lester,et al. Steady states, charge movements, and rates for a cloned GABA transporter expressed in Xenopus oocytes , 1993, Neuron.
[95] M. Caron,et al. Molecular characterization of the dopamine transporter. , 1993, Trends in pharmacological sciences.
[96] E. D. De Souza,et al. Interactions of [3H]amphetamine with rat brain synaptosomes. II. Active transport. , 1991, The Journal of pharmacology and experimental therapeutics.